Inside these posts: pharma

Visit our Filed page for categories. To browse by specific topic, see our Inside page. For a list of companies covered on this site, visit our Companies page.


Merck earnings take 52% hit in 2Q

Merck & Co.’s second-quarter earnings dropped 52 percnet on acquisition and other charges as sales of its key drugs weren’t as strong as in recent quarters.

The drug giant also narrowed its 2010 earnings forecast while trimming the top end of its sales view for the year. Get the full story »

Takeda to cut hundreds of jobs in Chicago area

By Bruce Japsen | The looming decline in sales from the blockbuster diabetes drug Actos
figured into Takeda Pharmaceutical Co.’s decision Wednesday to slash
nearly 1,600 U.S. jobs — including hundreds in Chicago’s northern

Japan’s largest drug maker operates from its U.S. base in Deerfield
under the name Takeda Pharmaceuticals North America Inc. It faces
competition in the next two years from upcoming generic versions of its
flagship product, the diabetes prescription Actos.

Get the full story »

AptarGroup sees strong first-quarter earnings

Dow Jones Newswires | Crystal Lake-based AptarGroup Inc.’s first-quarter earnings climbed by nearly half on strength in its core beauty-and-home segment, as the product-dispenser maker projected stronger earnings in the current quarter than analysts expected.

It sees earnings of 60 cents to 65 cents a share, above the average estimate of 56 cents a share from a survey of analysts by Thomson Reuters.

Get the full story »